The PCEV signature with the panel of markers including EGFR, EPCAM, MUC1, GPC1, and WNT2 showed improved specificity and sensitivity with an accuracy of 100% in distinguishing PC patients from healthy donors in a training cohort. The gene discussed is GPC1; the disease is pachyonychia congenita.